Is KPRX or KTTA more undervalued in 2026?

CirclFi compares Kiora Pharmaceuticals, Inc. (KPRX) and Pasithea Therapeutics Corp. (KTTA) using 13 institutional-grade valuation models. KPRX has a Quality of Company score of 5.5/10 while KTTA scores 4.1/10.

Which is a better buy — KPRX or KTTA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do KPRX and KTTA valuations compare?

KPRX at $2.83 and KTTA at $0.70 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

KPRX vs KTTA Valuation Comparison 2026 — Intrinsic Value Analysis

KPRX

Biotechnology

Kiora Pharmaceuticals, Inc.

Quality

5.5

out of 10

Value Trap

LOW

Price

$2.83

Last close

Models

9/13

Active

KTTA

Biotechnology

Pasithea Therapeutics Corp.

Quality

4.1

out of 10

Value Trap

SAFE

Price

$0.70

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	KPRX Fair Value	KPRX Upside	KTTA Fair Value	KTTA Upside
Bayesian DCF	Intrinsic	$2.06	-27.1%	$1.01	+45.1%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.48	-80.2%	$0.88	+26.8%
Dynamic NAV	Asset-Based	$4.83	+70.8%	$1.72	+147.3%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for KPRX vs KTTA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

KPRX vs KTTA — Which Stock Is More Undervalued?

KPRX scores higher with a 5.5/10 quality rating vs KTTA's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Kiora Pharmaceuticals, Inc. (KPRX) and Pasithea Therapeutics Corp. (KTTA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

KPRX currently trades at $2.83 with a QOC of 5.5/10, while KTTA trades at $0.70 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).